Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Ozempic Patent End: What Changes for Millions of Patients

Summary by SDPnoticias.com
On March 20, 2026, the patent of the Ozempic expired, the medicine created as a treatment for type 2 diabetes, but which has been popularized by its use for weight loss.With this, the semaglutide, the active substance of the treatment that was created by the Danish pharmaceutical company Novo Nordisk, can be produced generically and will change the lives of millions of patients.But what does the end of the Ozempic patent and the beginning of its…

1 Articles

SDPnoticias.comSDPnoticias.com
Lean Left

Ozempic Patent End: What Changes for Millions of Patients

On March 20, 2026, the patent of the Ozempic expired, the medicine created as a treatment for type 2 diabetes, but which has been popularized by its use for weight loss.With this, the semaglutide, the active substance of the treatment that was created by the Danish pharmaceutical company Novo Nordisk, can be produced generically and will change the lives of millions of patients.But what does the end of the Ozempic patent and the beginning of its…

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Left
100% Left

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

SDPnoticias.com broke the news in on Saturday, March 21, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

GLP-1 icon

GLP-1

Denmark icon

Denmark

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal